CPC A61K 31/522 (2013.01) [A61K 31/137 (2013.01); A61K 31/4985 (2013.01); A61K 45/06 (2013.01); A61P 33/06 (2018.01); A61K 2300/00 (2013.01)] | 21 Claims |
1. A pharmaceutical combination comprising about 400 mg to about 1000 mg lumefantrine formulated as a solid dispersion and about 200 mg to about 1000 mg of 2-amino-1-(2-(4-fluorophenyl)-3-(4-fluorophenylamino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)ethanone, or a pharmaceutically acceptable salt thereof.
|